Description
Ozempic (Semaglutide Injection) 2mg/0.75mL Single-Patient-Use Pen 3mL **Refrigerated Item**
Ozempic (Semaglutide Injection) 2mg/0.75mg Single-Patient-Use Pen 3mL. OzempicĀ® lowers fasting and postprandial blood glucose by stimulating insulin secretion in a glucose-dependent manner. With OzempicĀ®, the insulin secretion rate in patients with type 2 diabetes was similar to that of healthy subjects.
Brand: Novo Nordisk
NDC: 00169-4772-12
UPC: 301694-772120
Dose: 2mg/0.75mg
Type: Refrigerated Item